Salta al contenuto
Universidad del Mar SIBUMAR Descubridor Institucional UMAR
  • Inicio
  • Búsqueda avanzada
  • Explorar
  • Entra
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
Avanzata
  • Long‐Term Outcomes of Sofosbuvir/Velpatasvir Treatment for Hepatitis C Virus‐Related Decompensated Cirrhosis: A Retrospective Multicenter Cohort Study
Copertina

Long‐Term Outcomes of Sofosbuvir/Velpatasvir Treatment for Hepatitis C Virus‐Related Decompensated Cirrhosis: A Retrospective Multicenter Cohort Study

Fuente: Wiley Open Access
Salvato in:
Dettagli Bibliografici
Autori principali: Satoru Kakizaki, Tadashi Ikegami, Takeshi Hatanaka, Yuhei Suzuki, Takashi Hoshino, Atsushi Naganuma, Daichi Takizawa, Hirotaka Arai, Takashi Ueno, Keisuke Iizuka, Takahiro Arisaka, Yuichi Majima, Makoto Iijima, Shigeo Tano, Toshiyuki Tahara, Masahiro Araki, Toshiro Kamoshida, Yoshinari Takaoka, Hidekazu Kurata, Yukimura Fukaya, Kuniaki Fukuda, Atsuko Soeda, Takayoshi Suga, Shuichi Saito, Toru Fukuchi, Satoshi Takakusagi, Hitoshi Takagi, Katsuhiko Horiuchi, Yuki Kanayama, Toshiya Ohtake, Hiroki Tojima, Yuichi Yamazaki, Shunji Watanabe, Kouichi Miura, Naoki Morimoto
Natura: Artículo Open Access
Pubblicazione: Wiley 2026
Soggetti:
Hepatology Research
Accesso online:
Acceder al recurso
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
  • Citazione
  • Invia SMS
  • Invia email
  • Stampa
  • Esporta il record
    • Esporta a RefWorks
    • Esporta a EndNoteWeb
    • Esporta a EndNote
  • Aggiungi alla lista
  • PLink permanente
  • Posseduto
  • Descrizione
  • Commenti
  • Documenti analoghi
  • MARC21

Accesso online

https://onlinelibrary.wiley.com/doi/10.1111/hepr.70172

Documenti analoghi

  • Clinical Utility of the aMAP Risk Score for Predicting the Recurrence of Hepatic Encephalopathy After Rifaximin Treatment in Patients With Liver Cirrhosis: A Retrospective Cohort Study
    di: Satoshi Takakusagi, et al.
    Pubblicazione: (2026)
  • Sofosbuvir/Velpatasvir/Voxilaprevir Versus Sofosbuvir/Velpatasvir Plus Ribavirin in Patients With Hepatitis C Virus Genotype 3b and Compensated Cirrhosis: A Multicentre Randomized Controlled Trial
    di: Rui Huang, et al.
    Pubblicazione: (2025)
  • Successful Retreatment of Glecaprevir‐Pibrentasvir for Hepatitis C Virus Genotype 2a Infection in Patient Whose Cirrhosis Improved From Decompensation to Compensation After Sofosbuvir–Velpatasvir Therapy
    di: Tatsuo Kanda, et al.
    Pubblicazione: (2025)
  • Bioequivalence Study of Velpatasvir/Sofosbuvir Oral Coated Tablets in Healthy Volunteers Under Fasting Conditions
    di: Sergei Noskov, et al.
    Pubblicazione: (2024)
  • Response to Letter to ‘Serum CRP in Durvalumab–Tremelimumab‐Treated HCC : Expanding the Inflammatory Narrative’
    di: Takeshi Hatanaka, et al.
    Pubblicazione: (2025)
Universidad del Mar
Universidad del MarSistema Bibliotecario de la Universidad del MarDescubridor Institucional UMARImplementación y desarrollo: Mtro. Carlos Alonso Albores Pérez
InicioBúsqueda avanzadaExplorar
Visitas al Descubridor: 387,319© 2026 Universidad del Mar